Hepatitis B surface antigen (HBsAg) prevalence (%) in Bolivia
Bolivia: Hepatitis B surface antigen (HBsAg) prevalence was 0.1% in 2024. ◆ Volatile
Hepatitis B surface antigen (HBsAg) prevalence in Bolivia, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, hepatitis b surface antigen (hbsag) prevalence in Bolivia stood at 0.1%. That is the highest value across all 10 years on record.
Compared with earlier readings it is unchanged over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Bolivia peaked at 0.1% in 2015 and was at its lowest, 0.0%, in 2016.
That places Bolivia 101st out of 194 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Hepatitis B surface antigen (HBsAg) prevalence in Bolivia, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.1% | — |
| 2016 | 0.0% | -100.0% |
| 2017 | 0.0% | — |
| 2018 | 0.0% | — |
| 2019 | 0.0% | — |
| 2020 | 0.0% | — |
| 2021 | 0.0% | — |
| 2022 | 0.1% | — |
| 2023 | 0.1% | +0.0% |
| 2024 | 0.1% | +0.0% |
Bolivia compared with similar countries
- Bolivia's 0.1% is below the median for lower middle income countries, which is 0.6%, 17% of the median. (47 countries reporting)
- Bolivia's 0.1% is above the median for Latin America & Caribbean, which is 0.1%, 1.0× the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.0% | 0.0% | 0.1% | 5 |
| 2020s | 0.1% | 0.0% | 0.1% | 5 |
Countries ranked near Bolivia
- 101 Singapore 0.1% compare
- 101 Serbia 0.1% compare
- 101 Thailand 0.1% compare
- 101 Trinidad and Tobago 0.1% compare
- 101 Tunisia 0.1% compare
- 101 Ukraine 0.1% compare
- 101 Uzbekistan 0.1% compare
- 101 Albania 0.1% compare
- 101 Armenia 0.1% compare
- 101 Australia 0.1% compare
- 101 Belize 0.1% compare
- 101 Bhutan 0.1% compare
- 101 China 0.1% compare
- 101 Denmark 0.1% compare
- 101 Dominican Republic 0.1% compare
- 101 Algeria 0.1% compare
- 101 Gambia 0.1% compare
- 101 Guyana 0.1% compare
- 101 Hungary 0.1% compare
- 101 Israel 0.1% compare
- 101 Jordan 0.1% compare
- 101 Kyrgyzstan 0.1% compare
- 101 Lebanon 0.1% compare
- 101 Lithuania 0.1% compare
- 101 Malaysia 0.1% compare
- 101 Oman 0.1% compare
- 101 Peru 0.1% compare
- 101 Paraguay 0.1% compare
- 101 Romania 0.1% compare
- 101 Russia 0.1% compare
More health data for Bolivia
- Un projection of annual infant deaths, annual growth rate -2.04 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3723 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,159 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,250 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.2082 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.049 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.2019 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Bolivia?
- Hepatitis b surface antigen (hbsag) prevalence in Bolivia was 0.1% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Bolivia?
- The highest recorded value was 0.1% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Bolivia?
- The lowest recorded value was 0.0% in 2016.
- How does Bolivia rank for hepatitis b surface antigen (hbsag) prevalence?
- Bolivia ranks 101st out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Bolivia?
- Over the last ten years it is unchanged. The long-run trend across the full record is volatile.
- Where does this Bolivia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).